Six months ago, Tokyo-based Takeda Pharmaceutical closed a blockbuster $62 billion deal to buy Shire, promptly becoming the biggest life-sciences employer in Massachusetts. It inherited some 3,000 Shire workers in the state, mostly in Lexington and Cambridge, and now has a headcount of about 5,000.
That’s expected to grow in coming months.
